HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2.

Abstract
Cerebrovascular events have emerged as a central feature of the clinical syndrome associated with Sars-CoV-2 infection. This increase in infection-related strokes is marked by atypical presentations including stroke in younger patients and a high rate of hemorrhagic transformation after ischemia. A variety of pathogenic mechanisms may underlie this connection. Efforts to identify synergism in the pathophysiology underlying stroke and Sars-CoV-2 infection can inform the understanding of both conditions in novel ways. In this review, the molecular cascades connected to Sars-CoV-2 infection are placed in the context of the cerebral vasculature and in relationship to pathways known to be associated with stroke. Cytokine-mediated promotion of systemic hypercoagulability is suggested while direct Sars-CoV-2 infection of cerebral endothelial cells may also contribute. Endotheliopathy resulting from direct Sars-CoV-2 infection of the cerebral vasculature can modulate ACE2/AT1R/MasR signaling pathways, trigger direct viral activation of the complement cascade, and activate feed-forward cytokine cascades that impact the blood-brain barrier. All of these pathways are already implicated as independent mechanisms driving stroke and cerebrovascular injury irrespective of Sars-CoV-2. Recognizing the overlap of molecular pathways triggered by Sars-CoV-2 infection with those implicated in the pathogenesis of stroke provides an opportunity to identify future therapeutics targeting both Sars-CoV-2 and stroke thereby reducing the impact of the global pandemic.
AuthorsVisesha Kakarla, Naoki Kaneko, May Nour, Kasra Khatibi, Fanny Elahi, David S Liebeskind, Jason D Hinman
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (J Cereb Blood Flow Metab) Vol. 41 Issue 6 Pg. 1179-1192 (06 2021) ISSN: 1559-7016 [Electronic] United States
PMID33530831 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Proto-Oncogene Mas
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
Topics
  • Angiotensin-Converting Enzyme 2 (metabolism)
  • Blood-Brain Barrier (metabolism)
  • COVID-19 (complications, pathology, virology)
  • Cerebrovascular Disorders (etiology, metabolism)
  • Complement Activation
  • Humans
  • Proto-Oncogene Mas
  • Renin-Angiotensin System
  • Spike Glycoprotein, Coronavirus (metabolism)
  • Stroke (etiology, metabolism)
  • Virus Internalization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: